The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective

Shamshul Ansari*, John P Hays, Global AMR Insights Ambassador Network , Andrew Kemp, Raymond Okechukwu, Jayaseelan Murugaiyan, Mutshiene Deogratias Ekwanzala, Maria Josefina Ruiz Alvarez, Maneesh Paul-Satyaseela, Chidozie Declan Iwu, Clara Balleste-Delpierre, Ed Septimus, Lawrence Mugisha, Joseph Fadare, Susmita Chaudhuri, Vindana Chibabhai, J M Rohini W W Wadanamby, Ziad Daoud, Yonghong Xiao, Thulasiraman ParkunanYara Khalaf, Nkuchia M M'Ikanatha, Maarten B M van Dongen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

58 Citations (Scopus)
37 Downloads (Pure)


The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic's effect on global AMR.

Original languageEnglish
Article numberdlab038
JournalJAC-Antimicrobial Resistance
Issue number2
Publication statusPublished - Jun 2021

Bibliographical note

Funding: This study was supported by internal funding.

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.


Dive into the research topics of 'The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective'. Together they form a unique fingerprint.

Cite this